Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $667,200 - $922,800
-60,000 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $681,600 - $1.14 Million
60,000
60,000 $2.94 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $33.6B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track Glenn Welling's Portfolio

Track Glenn Welling Portfolio

Follow Glenn Welling (Engaged Capital LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engaged Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Engaged Capital LLC and Glenn Welling with notifications on news.